Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
18.32
-0.69 (-3.63%)
At close: Jan 23, 2026, 4:00 PM EST
18.44
+0.11 (0.63%)
After-hours: Jan 23, 2026, 5:07 PM EST
TNXP Market Cap
TNXP has a market cap or net worth of $227.01 million as of January 23, 2026. Its market cap has increased by 288.69% in one year.
Market Cap
227.01M
Enterprise Value
35.28M
1-Year Change
288.69%
Ranking
Category
Stock Price
$18.32
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $227.01M, an increase of 3,012.47%. That is a compound annual growth rate of 69.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 235.56M | 21.70% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 239.37M |
| Camp4 Therapeutics | 233.47M |
| Enlivex Therapeutics | 232.87M |
| Orchestra BioMed Holdings | 230.94M |
| Cabaletta Bio | 225.26M |
| Nuvectis Pharma | 220.03M |
| MediWound | 218.86M |
| Armata Pharmaceuticals | 217.71M |